Eli Lilly Debt Repayments decreased by 3.6% to $750.00M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2024), Debt Repayments shows a downward trend with a -41.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease may indicate a focus on capital preservation or refinancing, while a significant increase signals active debt reduction or maturity fulfillment.
Represents the total cash outflows used to reduce the principal balance of short-term and long-term debt obligations. Th...
Standard across all capital-intensive industries; peers with high leverage typically show higher repayment activity.
debt_repayment| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.91B | $100.00K | $710.10M | $849.90M | $0.00 | $0.00 | $0.00 | $0.00 | $166.00M | $166.00M | $166.00M | $166.00M | $0.00 | $778.10M | $750.00M |
| QoQ Change | — | — | -100.0% | >999% | +19.7% | -100.0% | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | -3.6% |
| YoY Change | — | — | — | — | — | -100.0% | -100.0% | — | — | — | — | — | — | -100.0% | +368.7% | — |